OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 44 filers reported holding OBALON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $395,000 | -30.5% | 274,399 | 0.0% | 0.01% | -37.5% |
| Q4 2018 | $568,000 | -33.3% | 274,399 | -13.0% | 0.01% | -27.3% |
| Q3 2018 | $852,000 | +25.5% | 315,504 | -0.1% | 0.01% | +22.2% |
| Q2 2018 | $679,000 | -20.2% | 315,790 | +27.3% | 0.01% | -30.8% |
| Q1 2018 | $851,000 | -53.4% | 248,044 | -10.2% | 0.01% | -50.0% |
| Q4 2017 | $1,826,000 | -30.6% | 276,211 | 0.0% | 0.03% | -29.7% |
| Q3 2017 | $2,632,000 | +9.3% | 276,211 | +13.7% | 0.04% | 0.0% |
| Q2 2017 | $2,407,000 | +13.8% | 242,893 | +22.8% | 0.04% | +2.8% |
| Q1 2017 | $2,115,000 | +139.0% | 197,805 | +97.8% | 0.04% | +111.8% |
| Q4 2016 | $885,000 | – | 100,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|